Advertisement

Picture Consultech GmbH Secure Funding with RnD Grants v7 650x100px

News > All

Total search results: 6381 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 62 63 64  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Amra Medical AB. (2/5/19). "Press Release: Amra Medical Appoints Allison Robbins as Chief Financial Officer". Linköping. 2019-02-05
Numares AG. (2/5/19). "Press Release: Numares and Mayo Clinic Laboratories Announce Collaboration to Develop New Diagnostic Tests Using Distinctive Nuclear Magnetic Resonance Technology". Regensburg & Rochester, MN. 2019-02-05
Argen-X N.V. (Argenx). (2/4/19). "Press Release: Argenx and Halozyme Enter Global Collaboration and License Agreement for ENHANZE Technology". Breda, Ghent & San Diego, CA. 2019-02-04
Sosei Group Corporation (d/b/a Sosei Heptares). (2/4/19). "Press Release: Sosei Heptares Announces Medicxi to Invest up to €40 Million in New Collaboration Based on Its Orexin Agonist Program". Tokyo & London. 2019-02-04
Avacta Group plc. (2/4/19). "Press Release: Moderna Exercises Option for an Exclusive Product License". 2019-02-04
Andrew Alliance S.A.. (2/4/19). "Press Release: Macherey-Nagel GmbH & Co. KG and Andrew Alliance Sign Co-Marketing Agreement". Geneva. 2019-02-04
Qiagen N.V.. (2/4/19). "Press Release: Qiagen Informatics Solutions Chosen to Support Genomics England’s Bold Five Million Genomes in Five Years Project". Hilden & London. 2019-02-04
Sanofi S.A.. (2/4/19). "Press Release: CHMP Recommends Approval of Praluent (alirocumab) to Reduce Cardiovascular Risk in People with Established Atherosclerotic Cardiovascular Disease". Paris & Tarrytown, NY. 2019-02-04
Genedata AG. (2/4/19). "Press Release: New Web-based Genedata Screener Showcases at SLAS2019". Washington, DC. 2019-02-04
Qiagen N.V.. (2/4/19). "Press Release: Qiagen Reports Results for Fourth Quarter and Full-year 2018". Venlo. 2019-02-04
Follicum AB. (2/4/19). "Press Release: Follicum’s New Topical Formulation of FOL-005 Results in Increased Hair Growth on a Par with Leading Commercial Product". 2019-02-04
ETH Zürich [Florian Meyer]. (2/4/19). "Press Release: Promoting Talents and New Ideas for Food Systems of the Future". 2019-02-04
CureVac AG. (2/4/19). "Press Release: CureVac Appoints Stefan Mueller, Ph.D., as Vice President Preclinical". Tübingen & Boston, MA. 2019-02-04
Memo Therapeutics AG. (2/1/19). "Press Release: Memo Therapeutics Announces the Development of a Droplet Sorter Enabling Functional Antibody Screening in a High-Throughput Format". 2019-02-01
Sirion Biotech GmbH. (2/1/19). "Press Release: Sirion Biotech Expands US Presence in Massachusetts". Cambridge, MA. 2019-02-01
Virometix AG. (2/1/19). "Press Release: Virometix AG Appoints New CEO". Schlieren. 2019-02-01
PepGen Ltd.. (2/1/19). "Press Release: PepGen’s £1.6M Grant from Innovate UK Has Commenced". 2019-02-01
Bayer AG. (1/31/19). "Press Release: Bayer and Kyoto University Form Research Alliance to Discover New Treatment Approaches against Lung Diseases [Not intended for U.S. and UK Media]". Berlin. 2019-01-31
Hitachi Chemical Co., Ltd.. (1/31/19). "Press Release: Notice Regarding the Stock Acquisition of Apceth Biopharma GmbH, a Contract Manufacturer of Regenerative Medicine Products". 2019-01-31
Apceth Biopharma GmbH. (1/31/19). "Press Release: Hitachi Chemical Co. Ltd. to Acquire Apceth Biopharma GmbH". Munich. 2019-01-31
Roche. (1/31/19). "Press Release: Roche Reports Very Strong Results in 2018. Group Sales Increase 7% at Constant Exchange Rates and in Swiss Francs". Basel. 2019-01-31
MeiraGTx Holdings plc. (1/31/19). "Press Release: MeiraGTx Enters into Strategic Collaboration with Janssen to Develop and Commercialize Gene Therapy Treatments for Inherited Retinal Diseases". London & New York, NY. 2019-01-31
MorphoSys AG. (1/31/19). "Press Release: MorphoSys Announces Settlement in Patent Lawsuit with Janssen and Genmab". Planegg. 2019-01-31
Symrise AG. (1/31/19). "Press Release: Symrise Strengthens Pet Food Activities and Expands US Footprint with Acquisition of ADF/IDF". 2019-01-31
Curetis N.V.. (1/30/19). "Press Release: Curetis’ Unyvero Application Cartridges Receive Regulatory Approvals in Malaysia and Thailand". Amsterdam & Holzgerlingen. 2019-01-30
Orphazyme A/S. (1/30/19). "Press Release: Orphazyme Reports Positive Results from Full Data Set of Phase II/III Arimoclomol Tria in Niemann-Pick Disease Type C (NPC)". Copenhagen. 2019-01-30
Dewpoint Therapeutics. (1/30/19). "Press Release: Dewpoint Therapeutics Launches with $60 Million Series A to Advance Proprietary Platform for Drugging Condensates". Cambridge, MA. 2019-01-30
Roche. (1/30/19). "Press Release: Roche to Discontinue Phase III CREAD 1 and 2 Clinical Studies of Crenezumab in Early Alzheimer’s Disease (AD) - other Company Programmes in AD Continue". Basel. 2019-01-30
Beckman Coulter Life Sciences. (1/30/19). "Press Release: Beckman Coulter Life Sciences Acquires Labcyte to Expand Laboratory Automation Business". Indianapolis, IN. 2019-01-30
Sanofi S.A.. (1/30/19). "Press Release: Fexinidazole, the First All-oral Treatment for Sleeping Sickness, Approved in Democratic Republic of Congo". Paris & Geneva. 2019-01-30
Lonza Group Ltd.. (1/30/19). "Press Release: Lonza Announces Succession of CEO. Richard Ridinger to Retire – Marc Funk Appointed CEO – Handover as of 1 March 2019". Basel. 2019-01-30
AC Immune S.A.. (1/30/19). "Press Release: AC Immune Reports Discontinuation of Phase III CREAD 1 and 2 Studies of Crenezumab in Alzheimer’s Disease". Lausanne. 2019-01-30
Marinomed Biotech AG. (1/29/19). "Press Release: Marinomed Sets Offer Price at 75 Euro per Share (Adhoc-News)". 2019-01-29
Marinomed Biotech AG. (1/29/19). "Press Release: Marinomed Announces Strong Investor Demand and Expected Offer Price (Adhoc-News)". 2019-01-29
BioStrata Ltd.. (1/29/19). "Press Release: BioStrata Announces New Hires to Drive Continued Growth across Its Specialist Marketing Communications Offering". Cambridge. 2019-01-29
Sphere Fluidics Ltd.. (1/29/19). "Press Release: Sphere Fluidics Closes $2 million USD (c. £1.5 million GBP) Investment Round". Cambridge. 2019-01-29
Optibrium Ltd.. (1/28/19). "Press Release: Optibrium Strengthens Senior Management Team with Financial Director Appointment". Cambridge. 2019-01-28
Allogene Therapeutics, Inc.. (1/28/19). "Press Release: Allogene Therapeutics, in Collaboration with Servier, Announces FDA Clearance of the IND for ALLO-501, an anti-CD19 Allogeneic CAR T (AlloCAR T™) Therapy". South San Francisco, CA & Paris. 2019-01-28
Horizon Discovery Group plc. (1/28/19). "Press Release: Horizon Discovery and Rutgers University Form Exclusive Partnership to Develop Next Generation Novel Gene Editing Technology". Cambridge. 2019-01-28
CureVac AG. (1/28/19). "Press Release: CureVac Appoints Dimitris Voliotis, M.D., Dr. med., as Chief Development Officer". Tübingen & Boston, MA. 2019-01-28
MorphoSys AG. (1/26/19). "Press Release: MorphoSys Announces That Its Patents Were Ruled Invalid in Patent Lawsuit Against Janssen and Genmab (Ad hoc)". Planegg. 2019-01-26
Genmab A/S. (1/26/19). "Press Release: Genmab Announces that the Patents Asserted against Darzalex in the United States Have Been Declared Invalid by Summary Judgment". Copenhagen. 2019-01-26
MaSTherCell Global, Inc.. (1/25/19). "Press Release: Great Point Partners-backed Strategic Partner MaSTherCell Global Announces Achievement of First Milestone Funding and Expansion with New Facility in Houston, Texas". Greenwich, CT & Houston, TX. 2019-01-25
Genomics England Ltd.. (1/25/19). "Press Release: Jonathan Symonds Appointed New Chair of Genomics England". 2019-01-25
AbbVie Inc.. (1/25/19). "Press Release: AbbVie Reports Full-Year and Fourth-Quarter 2018 Financial Results". North Chicago, IL. 2019-01-25
Boehringer Ingelheim. (1/24/19). "Press Release: Boehringer Ingelheim Partners with AMPATH to Scale Up Knowledge, Skills and Training for Healthcare Providers in Kenya". Ingelheim. 2019-01-24
Boehringer Ingelheim. (1/24/19). "Press Release: Boehringer Ingelheim Launches First Veterinary Vaccines Produced in China". Ingelheim. 2019-01-24
Merck KGaA. (1/24/19). "Press Release: Merck Grants Exclusive License to Vertex for Two DNA Damage Response Inhibitors [Not intended for UK- or US-based media]". Darmstadt. 2019-01-24
Cerenis Therapeutics S.A.. (1/24/19). "Press Release: 2018 Annual Results and Clinical Update". Toulouse & Lakeland, US. 2019-01-24
Biocartis Group N.V.. (1/23/19). "Press Release: Biocartis Successfully Raises EUR 55.50 Milion in an Equity Placement [NOT FOR US, AU, CA, JP, ZA, et al.]". Mechelen. 2019-01-23
Biocartis Group N.V.. (1/23/19). "Press Release: Biocartis Upsizes Its Equity Placement Due to Significant Demand [NOT FOR US, AU, CA, JP, ZA, et al.]". Mechelen. 2019-01-23
Biocartis Group N.V.. (1/23/19). "Press Release: Biocartis Launches Equity Placement [NOT FOR US, AU, CA, JP, ZA, et al.]". Mechelen. 2019-01-23
BioNTech AG. (1/23/19). "Press Release: BioNTech to Acquire Antibody Generation Unit of MAB Discovery". Mainz & Munich. 2019-01-23
Clariant International AG. (1/23/19). "Press Release: Clariant Partners with ExxonMobil and Renewable Energy Group to Advance Cellulosic Biofuel Research". Muttenz, Irving, TX & Ames, IA. 2019-01-23
Marinomed Biotech AG. (1/23/19). "Press Release: Marinomed Resumes Offer Period of the IPO (Adhoc-News)". 2019-01-23
Merck KGaA. (1/23/19). "Press Release: Merck and Tencent Announce Collaboration on Intelligent Digital Healthcare Services in China". Chengdu. 2019-01-23
Sartorius AG. (1/23/19). "Press Release: Sartorius Stedim Biotech Offers Services for Characterization of New Biological Entities (NBE)". Göttingen & Glasgow. 2019-01-23
Grifols S.A.. (1/23/19). "Press Release: Grifols Announces Collaboration and License Agreement with Rigel Pharmaceuticals to Commercialize Fostamatinib in Europe". Barcelona. 2019-01-23
Pharnext S.A.. (1/23/19). "Press Release: Pharnext Raises €15 Million without Discount". Paris. 2019-01-23
MyoKardia, Inc.. (1/23/19). "Press Release: MyoKardia Appoints William Fairey as Chief Commercial Officer". South San Francisco, CA. 2019-01-23
CRISPR Therapeutics AG. (1/22/19). "Press Release: CRISPR Therapeutics and ProBioGen Sign Collaboration and License Agreement to Develop Novel In Vivo Delivery Technologies". Cambridge, MA, Boston, MA & Berlin. 2019-01-22
Innovative Medicines Initiative (IMI). (1/22/19). "Press Release: Open Access Drug Development Tools Feature in New IMI Call for Proposals". Brussels. 2019-01-22
Scailyte AG. (1/22/19). "Press Release: Scailyte Raises CHF 2.75M in Seed Funding and Gains Swisscom Ventures and Zürcher Kantonalbank as Investors". 2019-01-22
Uniqure N.V.. (1/22/19). "Press Release: Uniqure Announces FDA Clearance of Investigational New Drug Application for AMT-130 in Huntington’s Disease". Lexington, MA & Amsterdam. 2019-01-22
Wren Therapeutics Ltd.. (1/22/19). "Press Release: Wren Therapeutics Completes £18 Million Series A Financing". Cambridge. 2019-01-22
EBD Group. (1/22/19). "Press Release: Biotech Showcase Celebrates Record Attendance by Life Science Investors, CEOs". New York, NY, San Francisco, CA & Carlsbad, CA. 2019-01-22
Genmab A/S. (1/22/19). "Press Release: Genmab Announces 2018 Net Sales Figures for Darzalex (Daratumumab)". Copenhagen. 2019-01-22
Genmab A/S. (1/22/19). "Press Release: Genmab Announces Initiation of U.S. FDA Regulatory Submission for Label Expansion of Daratumumab in Combination with Lenalidomide and Dexamethasone in Front Line Multiple Myeloma". Copenhagen. 2019-01-22
Grünenthal GmbH. (1/22/19). "Press Release: Fabian Raschke Appointed Chief Financial Officer (CFO)". Aachen. 2019-01-22
GlaxoSmithKline plc. (1/22/19). "Press Release: GSK Completes Acquisition of Tesaro, an Oncology Focused Biopharmaceutical Company". London. 2019-01-22
Voyager Therapeutics, Inc.. (1/22/19). "Press Release: Voyager Therapeutics Appoints Robert Hesslein as General Counsel". Cambridge, MA. 2019-01-22
OBN (UK) Ltd.. (1/22/19). "Press Release: OBN Announces the Success of 2nd Annual BioSeed 2019". Abingdon. 2019-01-22
Novo Holdings A/S. (1/21/19). "Press Release: Novo Holdings Announces New Investments by REPAIR Impact Fund. Four Investments Nade in First Year, Totalling €18 Million". Copenhagen. 2019-01-21
Alnylam Pharmaceuticals, Inc.. (1/21/19). "Press Release: Alnylam Pharmaceuticals and Medison Pharma Partner to Commercialize RNAi Therapeutics in Israel". Zug & Petach Tikva. 2019-01-21
Kurma Partners. (1/21/19). "Press Release: Kurma Partners Sees Great Opportunities for Early-stage Biotech Investments in Germany and Launches Operations in Munich". Paris & Munich. 2019-01-21
Marinomed Biotech AG. (1/21/19). "Press Release: Partnership in China and EIB Financing [Not for US, AU, CA, JP or any other jurisdiction where prohibited by applicable law]". Vienna. 2019-01-21
GlaxoSmithKline plc. (1/21/19). "Press Release: GSK Announces Succession Plan to Appoint New Chairman". 2019-01-21
Bavarian Nordic A/S. (1/18/19). "Press Release: Bavarian Nordic Announces Exercise of USD 44 Million Option by the U.S. Government under Contract for Freeze-dried MVA-BN Smallpox Vaccine". Copenhagen. 2019-01-18
Bruker Corporation. (1/18/19). "Press Release: Bruker Launches the G6 Leonardo for Oxygen, Nitrogen and Hydrogen (ONH) Analysis by Inert Gas Fusion". Delhi. 2019-01-18
Autifony Therapeutics Ltd.. (1/18/19). "Press Release: Autifony Therapeutics Achieves First Milestone in Agreement with Boehringer Ingelheim for a Novel Therapeutic Approach to a Range of CNS Disorders". Stevenage. 2019-01-18
Biond Biologics Ltd.. (1/8/19). "Press Release: Biond Biologics Announces $17 Million Series B Financing". Misgav. 2019-01-18
Miltenyi Biotec GmbH. (1/17/19). "Press Release: Miltenyi Biotec Acquires Promising Non-harmful Imaging Process". Bergisch Gladbach. 2019-01-17
MorphoSys AG. (1/17/19). "Press Release: MorphoSys Announces that Its Licensee Janssen Has Expanded Clinical Development of Guselkumab (Tremfya) into Ulcerative Colitis". Planegg. 2019-01-17
ImaBiotech SAS. (1/17/19). "Press Release: OCR and ImaBiotech Initiate a Strategic Partnership to Provide in situ Drug Efficacy and Target Exposure Services in Pets with Naturally Occuring Tumors". Lille. 2019-01-17
ImaBiotech SAS. (1/17/19). "Press Release: Metabrain Research and ImaBiotech Initiate a Strategic Partnership to Offer Cuttingedge Preclinical Research Services in Metabolic Disorders". Lille. 2019-01-17
Carbios S.A.. (1/17/19). "Press Release: Carbios and TWB Receive €7.5 Million Funding to Accelerate the Industrialization of the Biorecycling of PET Plastics and Fibers". Clermont-Ferrand. 2019-01-17
Boehringer Ingelheim. (1/17/19). "Press Release: Boehringer Ingelheim Biopharmaceuticals China Expands Commercial Manufacturing Capacities". Shanghai. 2019-01-17
BioMed X GmbH. (1/17/19). "Press Release: BioMed X and Boehringer Ingelheim to Investigate Early Intervention in Psychiatric Diseases". Heidelberg. 2019-01-17
Sanofi S.A.. (1/17/19). "Press Release: FDA Advisory Committee Votes on Zynquista (sotagliflozin) as Treatment for Adults with Type 1 Diabetes". Paris & The Woodlands, TX. 2019-01-17
Qiagen N.V.. (1/16/19). "Press Release: Qiagen Receives Approval for EGFR Test in Lung Cancer as Companion Diagnostic in Japan". Hilden & Tokyo. 2019-01-16
Nanobiotix S.A.. (1/16/19). "Press Release: Nanobiotix Plans to Conduct Registered Public Offering in the United States". Paris & Cambridge, MA. 2019-01-16
High-Tech Gründerfonds Management GmbH. (1/16/19). "Press Release: Series-A Investment for Munich-based Medical Technology Startup Mecuris". 2019-01-16
ADC Therapeutics S.A.. (1/16/19). "Press Release: ADC Therapeutics Announces First Patient Dosed in Phase I Clinical Trial of ADCT-601 in Advanced Solid Tumors". Lausanne. 2019-01-16
Agilent Technologies Inc.. (1/16/19). "Press Release: Mala Anand to Join Agilent's Board of Directors". Santa Clara, CA. 2019-01-16
Merck KGaA. (1/16/19). "Press Release: Merck Welcomes Ten New Startups to Its Innovation Center". Darmstadt. 2019-01-16
Valneva S.E.. (1/16/19). "Press Release: Valneva Announces New $59 Million Ixiaro Supply Contract with US Government". Saint-Herblain. 2019-01-16
Phico Therapeutics Ltd.. (1/15/19). "Press Release: Phico Therapeutics Appoints Financial Director and Two Non-Executives". Cambridge. 2019-01-15
Minoryx Therapeutics S.L.. (1/15/19). "Press Release: Minoryx Therapeutics Extends Its Activities in Belgium". Mataró, Barcelona & Charleroi. 2019-01-15
Tecan Group Ltd.. (1/15/19). "Press Release: Achim von Leoprechting Promoted to Become CEO of Tecan after Retirement of David Martyr". Männedorf. 2019-01-15
Biomunex Pharmaceuticals SASU. (1/15/19). "Press Release: Biomunex Pharmaceuticals Signs a Licensing Agreement with Sanofi for the Development of Bi- and Multi-specific Antibodies". Paris. 2019-01-15
next pagenext page 1 2 3 ... 62 63 64  next pagenext page



Advertisement

Picture Consultech GmbH Secure Funding with RnD Grants 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Advertisement

Picture EBD Group BIO-Europe 2024 Stockholm BEU24 650x300px

» top